Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis

Abstract Background and aim The association between iron-metabolism-related variables and liver fibrosis in chronic hepatitis C and nonalcoholic fatty liver disease is now well known. However, the relationship has not been extensively studied in autoimmune hepatitis (AIH). We aimed to investigate th...

Full description

Bibliographic Details
Main Authors: Qingling Chen, Min Gao, Hang Yang, Ling Mei, Rui Zhong, Ping Han, Peiyan Liu, Lili Zhao, Jing Wang, Jia Li
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-022-02098-z
_version_ 1798016296078540800
author Qingling Chen
Min Gao
Hang Yang
Ling Mei
Rui Zhong
Ping Han
Peiyan Liu
Lili Zhao
Jing Wang
Jia Li
author_facet Qingling Chen
Min Gao
Hang Yang
Ling Mei
Rui Zhong
Ping Han
Peiyan Liu
Lili Zhao
Jing Wang
Jia Li
author_sort Qingling Chen
collection DOAJ
description Abstract Background and aim The association between iron-metabolism-related variables and liver fibrosis in chronic hepatitis C and nonalcoholic fatty liver disease is now well known. However, the relationship has not been extensively studied in autoimmune hepatitis (AIH). We aimed to investigate the association between variables associated with iron metabolism and advanced liver fibrosis among untreated patients with AIH. Methods Ninety-seven untreated AIH patients were enrolled in this cross-sectional study. All participants underwent iron metabolism index detection and liver biopsy. Multiple logistic regression analysis was used to explore the association of iron-metabolism-related variables with advanced liver fibrosis. Results Among the 97 AIH patients, 38 (39.2%) had advanced liver fibrosis, and 59 (60.8%) did not. In multivariate logistic regression analysis, immunoglobulin G (odds ratio [OR], 1.123; 95% confidence interval [CI] 1.023–1.232, P = 0.014), platelet count (OR 0.988; 95% CI 0.979–0.997, P = 0.013), prothrombin time (OR 1.758; 95% CI 1.143–2.704, P = 0.010) and ferritin (OR 1.002; 95% CI 1.001–1.004, P = 0.012) were independent risk factors for predicting advanced liver fibrosis in AIH patients. Conclusion Higher serum ferritin was independently associated with advanced liver fibrosis among patients with treatment-naive AIH.
first_indexed 2024-04-11T15:48:39Z
format Article
id doaj.art-f1b6d1c2ea42426eb7e99346e3c34a11
institution Directory Open Access Journal
issn 1471-230X
language English
last_indexed 2024-04-11T15:48:39Z
publishDate 2022-01-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj.art-f1b6d1c2ea42426eb7e99346e3c34a112022-12-22T04:15:27ZengBMCBMC Gastroenterology1471-230X2022-01-012211910.1186/s12876-022-02098-zSerum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitisQingling Chen0Min Gao1Hang Yang2Ling Mei3Rui Zhong4Ping Han5Peiyan Liu6Lili Zhao7Jing Wang8Jia Li9Department of Hepatology, Second People’s Clinical College of Tianjin Medical UniversityDepartment of Hepatology, Tianjin Second People’s HospitalDepartment of Hepatology, Second People’s Clinical College of Tianjin Medical UniversityDepartment of Hepatology, Second People’s Clinical College of Tianjin Medical UniversityDepartment of Neurology, The First Hospital of Jilin UniversityDepartment of Hepatology, Tianjin Second People’s HospitalDepartment of Hepatology, Second People’s Clinical College of Tianjin Medical UniversityDepartment of Hepatology, Tianjin Second People’s HospitalDepartment of Hepatology, Tianjin Second People’s HospitalDepartment of Hepatology, Tianjin Second People’s HospitalAbstract Background and aim The association between iron-metabolism-related variables and liver fibrosis in chronic hepatitis C and nonalcoholic fatty liver disease is now well known. However, the relationship has not been extensively studied in autoimmune hepatitis (AIH). We aimed to investigate the association between variables associated with iron metabolism and advanced liver fibrosis among untreated patients with AIH. Methods Ninety-seven untreated AIH patients were enrolled in this cross-sectional study. All participants underwent iron metabolism index detection and liver biopsy. Multiple logistic regression analysis was used to explore the association of iron-metabolism-related variables with advanced liver fibrosis. Results Among the 97 AIH patients, 38 (39.2%) had advanced liver fibrosis, and 59 (60.8%) did not. In multivariate logistic regression analysis, immunoglobulin G (odds ratio [OR], 1.123; 95% confidence interval [CI] 1.023–1.232, P = 0.014), platelet count (OR 0.988; 95% CI 0.979–0.997, P = 0.013), prothrombin time (OR 1.758; 95% CI 1.143–2.704, P = 0.010) and ferritin (OR 1.002; 95% CI 1.001–1.004, P = 0.012) were independent risk factors for predicting advanced liver fibrosis in AIH patients. Conclusion Higher serum ferritin was independently associated with advanced liver fibrosis among patients with treatment-naive AIH.https://doi.org/10.1186/s12876-022-02098-zAutoimmune hepatitisFerritinIron metabolism disordersLiver fibrosis
spellingShingle Qingling Chen
Min Gao
Hang Yang
Ling Mei
Rui Zhong
Ping Han
Peiyan Liu
Lili Zhao
Jing Wang
Jia Li
Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
BMC Gastroenterology
Autoimmune hepatitis
Ferritin
Iron metabolism disorders
Liver fibrosis
title Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
title_full Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
title_fullStr Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
title_full_unstemmed Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
title_short Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis
title_sort serum ferritin levels are associated with advanced liver fibrosis in treatment naive autoimmune hepatitis
topic Autoimmune hepatitis
Ferritin
Iron metabolism disorders
Liver fibrosis
url https://doi.org/10.1186/s12876-022-02098-z
work_keys_str_mv AT qinglingchen serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT mingao serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT hangyang serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT lingmei serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT ruizhong serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT pinghan serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT peiyanliu serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT lilizhao serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT jingwang serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis
AT jiali serumferritinlevelsareassociatedwithadvancedliverfibrosisintreatmentnaiveautoimmunehepatitis